Delegates from the member boards of pharmacy adopted five resolutions during the National Association of Boards of Pharmacy® (NABP®) 115th Annual Meeting, held May 16-18, 2019, in Minneapolis, MN. The resolutions addressed the following:
- Convening a task force of stakeholders to evaluate and make recommendations to NABP regarding the education requirements, practice responsibilities, and competence assessments for pharmacy technicians;
- Engaging stakeholders, including, but not limited to, the US Department of Health and Human Services, the National Council for Prescription Drug Programs, and the Tri-Regulator Collaborative, to encourage prescribers and pharmacists to use e-prescribing transactions, such as “RxChange” and “CancelRx,” to avoid duplicative or inappropriate prescribing and medication therapy (“de-prescribing”);
- Requesting FDA to clarify and standardize recall procedures for products prepared in 503B outsourcing facilities in accordance with the recall procedures for manufactured products; and
- Encouraging the Institute for Safe Medication Practices, the American Association of Colleges of Pharmacy, and other stakeholders to undertake efforts to obtain objective data analysis to determine the impact of workload, working conditions, and related topics on substantiated patient safety outcomes.
Additionally, a recognition resolution honoring members of the Association who have passed away was approved.
The complete text of the resolutions will be available in the Publications and Reports section of the NABP website, www.nabp.pharmacy, at the end of May 2019 and will also be published in the forthcoming Special Annual Meeting Issue of Innovations®.
NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.